Format

Send to

Choose Destination
Br J Cancer. 2007 Jun 18;96(12):1904-7. Epub 2007 May 22.

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.

Author information

1
Section of Cancer Genetics, Institute of Cancer Research, Surrey, UK.

Abstract

The Gly388Arg polymorphism in the fibroblast growth factor receptor 4 (FGFR4) gene has been reported to influence prognosis in a wide variety of cancer types. To determine whether Gly388Arg is a marker for lung cancer prognosis, we genotyped 619 lung cancer patients with incident disease and examined the relationship between genotype and overall survival. While we employed a comprehensive set of statistical tests, including those sensitive to the detection of differences in early survival, our data provide little evidence to support the tenet that the FGFR4 Gly388Arg polymorphism is a clinically useful marker for lung cancer prognosis.

PMID:
17519899
PMCID:
PMC2359960
DOI:
10.1038/sj.bjc.6603816
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center